KROS
Price
$15.62
Change
-$0.00 (-0.00%)
Updated
Oct 7, 02:17 PM (EDT)
Capitalization
634.41M
23 days until earnings call
NAUT
Price
$0.86
Change
-$0.01 (-1.15%)
Updated
Oct 7, 01:23 PM (EDT)
Capitalization
109.27M
28 days until earnings call
Interact to see
Advertisement

KROS vs NAUT

Header iconKROS vs NAUT Comparison
Open Charts KROS vs NAUTBanner chart's image
Keros Therapeutics
Price$15.62
Change-$0.00 (-0.00%)
Volume$300
Capitalization634.41M
Nautilus Biotechnolgy
Price$0.86
Change-$0.01 (-1.15%)
Volume$100
Capitalization109.27M
KROS vs NAUT Comparison Chart in %
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KROS vs. NAUT commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KROS is a StrongBuy and NAUT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 07, 2025
Stock price -- (KROS: $15.62 vs. NAUT: $0.87)
Brand notoriety: KROS and NAUT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KROS: 94% vs. NAUT: 83%
Market capitalization -- KROS: $634.41M vs. NAUT: $109.27M
KROS [@Biotechnology] is valued at $634.41M. NAUT’s [@Biotechnology] market capitalization is $109.27M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KROS’s FA Score shows that 1 FA rating(s) are green whileNAUT’s FA Score has 1 green FA rating(s).

  • KROS’s FA Score: 1 green, 4 red.
  • NAUT’s FA Score: 1 green, 4 red.
According to our system of comparison, NAUT is a better buy in the long-term than KROS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KROS’s TA Score shows that 4 TA indicator(s) are bullish while NAUT’s TA Score has 6 bullish TA indicator(s).

  • KROS’s TA Score: 4 bullish, 4 bearish.
  • NAUT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NAUT is a better buy in the short-term than KROS.

Price Growth

KROS (@Biotechnology) experienced а -2.07% price change this week, while NAUT (@Biotechnology) price change was +7.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.75%. For the same industry, the average monthly price growth was +16.07%, and the average quarterly price growth was +89.17%.

Reported Earning Dates

KROS is expected to report earnings on Oct 30, 2025.

NAUT is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Biotechnology (+7.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KROS($634M) has a higher market cap than NAUT($109M). KROS YTD gains are higher at: -1.327 vs. NAUT (-48.506). KROS has higher annual earnings (EBITDA): 25.5M vs. NAUT (-68.6M). KROS has more cash in the bank: 690M vs. NAUT (148M). KROS has less debt than NAUT: KROS (18M) vs NAUT (28.2M). KROS has higher revenues than NAUT: KROS (233M) vs NAUT (0).
KROSNAUTKROS / NAUT
Capitalization634M109M582%
EBITDA25.5M-68.6M-37%
Gain YTD-1.327-48.5063%
P/E Ratio48.81N/A-
Revenue233M0-
Total Cash690M148M466%
Total Debt18M28.2M64%
FUNDAMENTALS RATINGS
NAUT: Fundamental Ratings
NAUT
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KROSNAUT
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 7 days ago
79%
Bearish Trend 21 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYKIX116.45N/A
N/A
Rydex Banking Inv
ITHSX57.72N/A
N/A
Hartford Capital Appreciation R4
NCGFX72.00N/A
N/A
New Covenant Growth
GLCRX32.49N/A
N/A
Goldman Sachs Large Cap Gr Insghts R
GSZPX31.63N/A
N/A
Goldman Sachs Small Cap Gr Insghts P

NAUT and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAUT has been loosely correlated with AXON. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if NAUT jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAUT
1D Price
Change %
NAUT100%
-1.98%
AXON - NAUT
42%
Loosely correlated
+0.85%
ARRY - NAUT
38%
Loosely correlated
-1.54%
KROS - NAUT
36%
Loosely correlated
-2.01%
RXRX - NAUT
36%
Loosely correlated
+0.73%
FHTX - NAUT
36%
Loosely correlated
-2.37%
More